Scarica l'app Stockscreener
822.51
0.10%
0.84
Dopo l'orario di chiusura:
820.60
-1.91
-0.23%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LLY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Lilly Eli Co Borsa (LLY) Ultime notizie
Eli Lilly Alzheimer’s Drug Kisunla Fails to Get EU Backing - Mint
Eli Lilly Stock Up 1% After Key Signal, Despite S&P 500's ~2% Drop - Benzinga
European Drug Regulator Gives Thumbs Down To Eli Lilly's Alzheimer's Drug, Analyst Says It Is Incremental Win For Biogen - Benzinga
Eli Lilly's Alzheimer's drug is rejected by EU regulators over brain swelling risk, despite U.S. approval - Yahoo
European committee says Lilly Alzheimer's drug shouldn't get marketing approval - The Times of Northwest Indiana
European committee says Lilly Alzheimer’s drug shouldn’t get marketing approval - Winnipeg Free Press
Eli Lilly's Alzheimer's drug rejected in Europe - Reuters
Eli Lilly’s Alzheimer’s drug gets thumbs down from EU regulator - Sherwood News
Eli Lilly Alzheimer’s Drug Kisunla Fails To Get EU Backing - NDTV Profit
Billionaire Ken Fisher’s #2 Low Vol Stock Pick: Eli Lilly & Company (LLY) - Insider Monkey
Eli Lilly Alzheimer’s drug fails to win EU nod (LLY:NYSE) - Seeking Alpha
EU regulator declines approval for Eli Lilly’s new Alzheimer’s drug - Financial Times
Eli Lilly’s Alzheimer’s drug gets thumbs-down from European regulators - STAT
Eli Lilly Remains Confident In The Safety And Effectiveness Of Donanemab - Marketscreener.com
Lilly stock dips as Kisunla misses EU approval By Investing.com - Investing.com South Africa
Lilly’s statement about the CHMP opinion issued for donanemab | Eli Lilly and Company - Investors | Eli Lilly and Company
Eli Lilly & Co. (LLY) call put ratio 1 call to 1.3 puts - StreetInsider.com
Lilly adds Alzheimer's to online offerings - Reuters
Here's How Much $1000 Invested In Eli Lilly 20 Years Ago Would Be Worth Today - Benzinga
Eli Lilly Says Michigan AG's Insulin Pricing Probe Is Baseless - Law360
Eli Lilly and Company (LLY): Among Dividend Zombies to Invest in - Yahoo Finance
Eli Lilly expands LillyDirect to include Alzheimer's resources - Seeking Alpha
Eli Lilly taps Chicago startup as it expands digital health platform - Crain's Chicago Business
Eli Lilly's online health platform just expanded beyond weight loss to tackle Alzheimer’s - Yahoo
Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025 - AOL
LillyDirect Platform Expands To Facilitate Access To Alzheimer's Disease Care - Marketscreener.com
LillyDirect platform expands to facilitate access to Alzheimer's disease care - Investors | Eli Lilly and Company
In a first, Eli Lilly to connect patients to telehealth providers of Alzheimer’s care - STAT
Revolutionary Digital Platform Cuts Alzheimer's Care Wait Times from Years to Days - StockTitan
Eli Lilly comms head Kathryn Beiser resigns - PR Week
Eli Lilly's GLP-1 pill could be the next key in obesity treatment - Yahoo Finance
Eli Lilly and Company (LLY): One of Two Sigma Investments’ Top Stock Picks - Yahoo Finance
Eli Lilly (LLY) Stock: Why Analysts See 30% Upside Potential - MoneyCheck
Eli Lilly, Palo Alto Networks Traders Take Note: Direxion's New Leveraged ETFs Are Here - Benzinga
Eli Lilly CEO invites job seekers for new Hyderabad tech hub | Exclusive - CNBCTV18
Mounjaro: Here Is How Eli Lilly Shares Have Performed Since The Launch Its Own Ozempic - Free Press Journal
Eli Lilly plans to expand insulin access for diabetics, NCD therapies in India - Business Today
Open to tie-ups in India for selling Mounjaro: Eli Lilly CEO David Ricks - The Economic Times
Eli Lilly (LLY) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Lilly announces details of presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting - Quantisnow
Lilly Announces Details Of Presentations At 2025 American Association For Cancer Research (AACR) Annual Meeting - Marketscreener.com
Lilly Unveils Groundbreaking Cancer Drug Pipeline: Dual Phase 1 Programs Target KRAS and SMARCA4 Mutations - StockTitan
Global CEO Of Eli Lilly, World’s Pioneer Insulin Manufacturing Company, David Ricks Called On Union Minister Dr. Jitendra Singh To Discuss Strengthening Partnership, With A Focus On Insulin And NCD Therapies As Well As Biomanufacturing. - TRIPURA STAR NEWS
Bernstein reiterates Eli Lilly outperform with $1100 target - Investing.com
Eli Lilly GC Made Nearly $7.5M In 2024 - Law360
Bernstein reiterates Eli Lilly outperform with $1100 target By Investing.com - Investing.com UK
Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company - Quantisnow
Novo Nordisk follows Eli Lilly with its own ‘triple-G’ drug - STAT
Is Eli Lilly and Company (NYSE:LLY) The Best Stocks to Buy Now For the Long Term? - Insider Monkey
Eli Lilly Shares Rise Over 2% After Key Signal - Benzinga
1.27%
1.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):